Immunology cohort study

Key publications

SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
Tea F, Ospina Stella A, Aggarwal A ... Hoad VC, Irving DO, Dore GJ, Gosbell IB, Kelleher AD, Matthews GV, Brilot F, Turville SG.
PLoS Med
Jul 6;18(7):e1003656. doi: 10.1371/journal.pmed.1003656. eCollection 2021 Jul.
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
Aggarwal A, Stella AO, Walker G, ... Rawlinson WD, Kelleher AD, Turville SG.
Nat Microbiol.
2022 Jun;7(6):896-908. doi: 10.1038/s41564-022-01135-7. Epub 2022 May 30.PMID: 35637329
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
Aggarwal A, Akerman A, Milogiannakis V, ... Rawlinson WD, Kelleher AD, Turville SG.
Oct;84:104270. doi: 10.1016/j.ebiom.2022.104270. Epub 2022 Sep 18.